altimmune stock forecast 2021

Altimmune Target Price Projection. However, solely looking at the historical price movement is usually misleading. Do Options Traders Know Something About Altimmune (ALT) Stock We Don't? Positive news sentiment. Short-term (time horizon: 2 weeks) ALTIMMUNE INC share price prediction for 2021-08-06 with daily closed price projections Is Altimmune Stock a good buy in 2021, according to Wall Street analysts? Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. “The commencement of our Phase 1 clinical trial of AdCOVID is an important milestone for our company and the global healthcare community in our fight against the SARS-CoV-2 virus,” said Dr. Scott Harris, Chief Medical Officer of Altimmune. The high price target for … Altimmune Inc. [NASDAQ: ALT] closed the trading session at $12.05 on 05/24/21. At the same time, oil is returning to the area of its autumn 2018 peaks (Brent had then exceeded USD 86), i.e. In finance, a ALT stock forecast 2021 (SSF) is a type of futures contract between two parties to exchange a specified number of stocks in Altimmune for a price agreed today (the ALT futures price 2021 or the strike price) with delivery occurring at a specified future date, the delivery date. Zacks. Altimmune Stock Forecast is based on your current time horizon. On average, they expect Altimmune's stock price to reach $35.83 in the next year. 7 Wall Street analysts have issued 1 year price objectives for Altimmune's stock. On average, they expect Altimmune's stock price to reach $35.83 in the next year. In the medium term (3months), ALT's stock price should underperform the market by -5.70%. The contracts are traded on a futures exchange. Altimmune Stock Forecast is based on your current time horizon. Weighted Average Shares Diluted is likely to gain to about 27.7 M in 2021. On May 08 2021 Altimmune was traded for 13.27 at the closing time. The company's cash burn rate will probably rise a great deal in 2021 as more clinical trials with ALT-801 as a treatment for different patient groups begin. Altimmune Stock Forecast is based on your current time horizon. Jun 07, 2021. The market (NASDAQ average) beta is 1, while Altimmune's is 1.3064. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19. ALT stock futures 2021. If you had invested in Altimmune stock at $2,100.00, your return over the last 15 years would have been -99.22%, for an annualized return of -27.62%. Price target in 14 days: 18.459 USD. Highest Altimmune's price during the trading hours was 13.59 and the lowest price during the day was 12.91. The company’s stock price has collected -15.02% of loss in the last five trading sessions. Yet analysts are ramping up their growth forecast for the fiscal year 2021. (Altimmune Inc) 10-Day ALT stock forecast by pretiming. Last updated 2021/06/09 08:06. Based on our forecasts, a long-term increase is expected, the "ALT" fund price prognosis for 2026-06-10 is 34.439 USD. Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management; Ownership; Company … Altimmune's current and average target prices are 12.73 and 42.67, respectively. Altimmune finished March with $226.5 million in cash after burning through $14.9 million in the first quarter. Analysts covering Altimmune Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.117 for the next financial year. On average, analysts forecast that ALT's … In the short term (2weeks), ALT's stock price should outperform the market by 0.19%.During that period the price should oscillate between -11.33% and +15.32%.. With Altimmune stock trading at $16.46 per share, the total value of Altimmune stock (market capitalization) is $632.01M. Home Stocks Discover Watchlist Portfolios Screener. Altimmune has confirmed that its next quarterly earnings report will be published on Monday, May 17th, 2021. The average Altimmune stock price prediction forecasts a potential downside of N/A from the current ALT share price of $16.46. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. This suggests a possible upside of 117.7% from the stock's current price. Jun 17, 2021 1:15AM EDT A ltimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. At that level they are trading at 0.148% discount to the analyst consensus target price of 0.00. Altimmune, Inc (ALT) Forecast, Long-Term Predictions for Next Months and Year: 2021, 2022 Walletinvestor.com Altimmune, Inc price forecast* for tomorrow, and … Altimmune, Inc. (NASDAQ:ALT) – Stock analysts at Piper Sandler dropped their Q4 2021 earnings per share estimates for Altimmune in a research note issued on Thursday, February 25th. Please note that any opinions, estimates or forecasts regarding Altimmune's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Altimmune or its management. ALT stock forecast Our latest prediction for Altimmune Inc's stock price was made on the June 15, 2020 when the stock price was at 7.60$.. On average, analysts forecast that ALT's … Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; FAQ; Consensus Rating: Buy; Consensus Price Target: $32.40; Forecasted Upside: 150.19 %; Number of Analysts: 7; Breakdown: 0 Sell Ratings; 0 Hold Ratings; 7 Buy Ratings; 0 Strong Buy Ratings $ 12.95 As of 06/4/2021 01:00 AM ET +0.03 (0.23%) 1 … Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. Investors need to pay close attention to Altimmune (ALT) stock based on the movements in the options market lately. Altimmune Inc. (ALT) shares have gone up 17.56% during the last six months, with a year-to-date growth rate more than the industry average at 37.70% against 16.40. (NASDAQ: ALT) Altimmune's current Earnings Per Share (EPS) is -$2.03. With the market capitalization of Altimmune, Inc. currently standing at about $498.36 Million, investors are eagerly awaiting this quarter’s results, scheduled for Aug 09, 2021- Aug 13, 2021. Earnings Preview: Altimmune, Inc. (ALT… Analyst projections state that ALT is forecast to be at a low of $24 and a high of $80. 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Altimmune in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Altimmune stock. View analyst ratings for Altimmune or view top-rated stocks. Share on Facebook. ALT stock forecast Our latest prediction for Altimmune Inc's stock price was made on the June 15, 2020 when the stock price was at 7.60$.. Analysts have predicted the quarterly earnings per share to grow by -$0.49 per share this quarter, however they have predicted annual earnings per share of -$2.12 for 2021 and -$1.99 for 2022. The reported ($0.38) EPS for the quarter, topping analysts' consensus estimates of ($0.39) by $0.01. But there are still attractive options out there -- if you know where to look. The company’s Forward Dividend Ratio is 0, with its dividend yield at 0%. The company report on May 17, 2021 that Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate Update. Over the last 12 months, Altimmune's shares have ranged in value from as little as $4.36 up to $35.1. In order for the stock price to hit the forecast high, the stock would need to surge +478.03% from its current level, while the stock would need to crash 73.41% from its current level to reach the projected low. Altimmune last released its earnings data on May 16th, 2021. 09 Aug 2021 - 13 Aug 2021: Forward dividend & yield: N/A (N/A) Ex-dividend date: 20 Jan 2017: 1y target est: 40.86: All. Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. GAITHERSBURG, Md., May 11, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2021 financial result... 1 month ago - GlobeNewsWire Altimmune's Intranasal COVID-19 Vaccine Candidate Shows Sterilizing Immunity After Single Dose This suggests a possible upside of 117.7% from the stock's current price. Altimmune, Inc quote is equal to 16.460 USD at 2021-06-17. GAITHERSBURG, Md., May 11, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2021 … Stock Analysis Report. During that period the price should oscillate between -11.33% and +15.32%. Next reporting date: August 17, 2021: EPS forecast (this quarter)-$0.03: Annual revenue (last year) $8.2M: Annual profit (last year)-$49.0M: Net profit margin ALTIMMUNE INC stock price forecast for further price development down to -2.91% (time horizon: 1 day) and price target of 13.85 USD. Piper Sandler analyst Y. Rahimi now anticipates that the company will post earnings per share of $2.00 for the quarter, down from their previous estimate of $2.20. The company's cash burn rate will probably rise a great deal in 2021 … Flawless balance sheet with limited growth. Weighted Average Shares is likely to gain to about 27.7 M in 2021. 6 equities research analysts have issued 1 year price objectives for Altimmune's stock. Their forecasts range from $25.00 to $41.00. On average, they anticipate Altimmune's share price to reach $31.75 in the next year. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! News. In finance, a ALT stock forecast 2021 (SSF) is a type of futures contract between two parties to exchange a specified number of stocks in Altimmune for a price agreed today (the ALT futures price 2021 or the strike price) with delivery occurring at a specified future date, the delivery date. The contracts are traded on a futures exchange. On stock markets, this is reflected in clearly visible bouts of weakness in the commodity champions this week, while oil groups continue to hover at the top of the charts. Piper Sandler analyst Y. Rahimi now anticipates that the company will post earnings per share of $2.00 for the quarter, down from their previous estimate of $2.20. Get the hottest stocks to trade … ALT. NASDAQ:ALT - Altimmune Stock Price Target and Predictions. The move was backed by solid volume with far more shares … A popular way to gauge a stock's volatility is its "beta". Receivables Turnover is likely to gain to 3.24 in 2021, whereas Accounts Payable Turnover is likely to drop 21.61 in 2021. . Analyst Opinion on Altimmune (NASDAQ:ALT) 6 Wall Street analysts have issued ratings and price targets for Altimmune in the last 12 months. Your current $100 investment may be up to $430.31 in 2026. About the Altimmune, Inc. stock forecast. Our latest prediction for Altimmune Inc's stock price was made on the June 15, 2020 when the stock price was at 7.60$. ALTIMMUNE, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ALTIMMUNE, INC. Stock | ALT | US02155H2004 In the short term (2weeks), ALT's stock price should outperform the market by 0.19%.During that period the price should oscillate between -11.33% and +15.32%.. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. Shares in Altimmune Inc are currently priced at $15.86. What is ALT's Earnings Per Share (EPS) forecast for 2021-2023? (NASDAQ: ALT) Altimmune's current Earnings Per Share (EPS) is -$2.03. The average Altimmune stock price prediction forecasts a potential downside of N/A from the current ALT share price of $16.46. Altimmune has generated ($1.91) earnings per share over the last year. NasdaqGM:ALT. 1. Close price at the end of the last trading day (Thursday, 3rd Jun 2021) of the ALT stock was $12.92. Altimmune, Inc. (NASDAQ:ALT) – Stock analysts at Piper Sandler dropped their Q4 2021 earnings per share estimates for Altimmune in a research note issued on Thursday, February 25th. With a 5-year investment, the revenue is expected to be around +109.23%. What is ALT's Earnings Per Share (EPS) forecast for 2021-2023? Investors can use this forecasting interface to forecast Altimmune historical stock prices and determine the direction of Altimmune's future trends based on various well-known forecasting models. Altimmune Inc. (NASDAQ:ALT) went down by -13.99% from its latest closing price compared to the recent 1-year high of $35.10. 3 Coronavirus Stocks Poised to Soar in 2021 | The Motley Fool Investors can use this forecasting interface to forecast Altimmune historical stock prices and determine the direction of Altimmune's future trends based on various well-known forecasting models. Should you invest in Altimmune (NasdaqGM:ALT)? We assume companies with shrinking free cash flo… Closed price 13.40 . Share on Twitter. With a 5-year investment, the revenue is expected to be around +330.31%. AC Investment Inc. delivers machine learning based share price forecast. The Altimmune, Inc. stock price fell by -0.91% on the last day (Tuesday, 15th Jun 2021) from $14.26 to $14.13. AC Investment Inc. delivers AI check for Credit Rating, rating, news, stock, financials, financial information, fund, dividend, price forecast. Their average twelve-month price target is $31.75, predicting that the stock has a possible upside of 137.29%. NEW YORK, June 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CATB, ARVL, MNKD, TRVN, and ALT. In the medium term (3months), ALT's stock price should underperform the market by -5.70%. On the other hand, Altimmune's target price is what analysts think the stock … Altimmune is followed by the analysts listed above. Altimmune Stock Forecast, ALT stock price prediction. Their forecasts range from $25.00 to $53.00. The average equity rating for QFIN stock is currently 1.60, trading closer to a bullish pattern in the stock market. The current price of Altimmune is the price at which Altimmune is currently trading. its best level of the 2014 / 2021 period. The move was backed by solid volume with far more shares changing hands than in a … Altimmune: Q2 2021 Holds Large Upside Potential With 3 Trial Data Readouts ... Altimmune (NASDAQ:ALT): Is ALT Stock A Buy On Upcoming Catalysts in Q2-2021? ALT Stock Trend The stock lies in the middle of a very wide and falling trend in … The net volume was 656 K. The overall trading history on the 8th of May did not affect price variability. I view Altimmune as just that kind of under-the-radar stock that could be a huge winner in 2021. Revenue is predicted to grow 47.90% this quarter and then drop -1.90% in the quarter after that. Zacks. Press releases . 2. Based on our forecasts, a long-term increase is expected, the "ALT" stock price prognosis for 2026-06-01 is 62.782 USD. Altimmune Inc quote is equal to 14.590 USD at 2021-06-14. What are ALT earnings? Altimmune anticipates having a full data readout from this Phase 1 study in Q2 2021. Your current $100 investment may be up to $209.23 in 2026. AC Investment Inc. delivers machine learning based share price forecast. The Phase 1 clinical trial will evaluate the safety and immunogenicity of AdCOVID in up to 180 healthy adult volunteers between the ages of 18 and 55. Subjects will receive AdCOVID at one of three dose levels administered as a nasal spray. Beta is a measure of a share's volatility in relation to the market. When is ALT earnings date? Is Altimmune Stock a good buy in 2021, according to Wall Street analysts? Press Release reported on 05/17/21 that Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate Update. To start off with, we need to estimate the next ten years of cash flows. The one-year 360 DigiTech Inc. stock forecast points to a potential downside of -13.53. Tags Alt Altimmune Buy Catalysts NASDAQALT Q22021 stock Upcoming. ALT stock forecast Our latest prediction for Altimmune Inc's stock price was made on the June 15, 2020 when the stock price was at 7.60$.. In the short term (2weeks), ALT's stock price should outperform the market by 0.19%.During that period the price should oscillate between -11.33% and +15.32%.. It means analysts are expecting annual earnings per share growth of 0.11% this year and -0.06% next year. Generally the first stage is higher growth, and the second stage is a lower growth phase. As of 2021 June 17, Thursday current price of ALT stock is 14.310$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Altimmune stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Altimmune, Inc. (ALT) projections and forecasts The stock market's rally through the late stages of the pandemic has pushed dividend yields lower and made it harder for income investors to find bargains. 3.47% Suitable Investment Position => Sell Stock market timing forecast by pretiming The strength of supply and demand(S&D) has changed from a weak buying flow to a suddenly strengthening buying flow and it's in the midst of a rebounding trend of upward direction box pattern price flow … See Altimmune, Inc. (ALT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. During the day the stock fluctuated 2.74% from a day low at $12.79 to a day high of $13.14. ALT stock futures 2021. and has now fallen 3 days in a row.During the day the stock fluctuated 10.36% from a day low at $13.99 to a day high of $15.44.The price has risen in 6 of the last 10 days and is up by 13.4% over the past 2 weeks.